These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31156236)

  • 1. [Diagnostic value of antibodies to myelin oligodendrocyte glycoprotein in demyelinating diseases of the central nervous system].
    Shchepareva ME; Kochergin IA; Tolpeeva OA; Shabalina AA; Zakharova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2. Vyp. 2):18-23. PubMed ID: 31156236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
    Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
    J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and biochemical characteristics of atypical variants of multiple sclerosis].
    Shchepareva ME; Skalnaya AA; Zakharova MN; Shabalina AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):81-86. PubMed ID: 31934992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
    López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
    JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
    Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K
    Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Genetic Variants Distinguishing Myelin Oligodendrocyte Glycoprotein-IgG-Positive From Myelin Oligodendrocyte Glycoprotein-IgG-Negative Pediatric Acute Disseminated Encephalomyelitis in Northern China.
    Cui Y; Wu B; Wu J; Zhang S; Guo P; Shu J; Li D; Cai C
    Pediatr Neurol; 2024 Jul; 156():155-161. PubMed ID: 38781724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases.
    Mariotto S; Gajofatto A; Batzu L; Delogu R; Sechi G; Leoni S; Pirastru MI; Bonetti B; Zanoni M; Alberti D; Schanda K; Monaco S; Reindl M; Ferrari S
    Neurology; 2019 Nov; 93(20):e1867-e1872. PubMed ID: 31645473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
    Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
    Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic modalities in multiple sclerosis: perspectives in children.
    Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS
    Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein.
    Lei M; Cui Y; Dong Z; Zhi X; Shu J; Cai C; Li D
    Front Pediatr; 2022; 10():859932. PubMed ID: 35669399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China.
    Shen J; Lin D; Jiang T; Gao F; Jiang K
    BMC Neurol; 2022 Nov; 22(1):418. PubMed ID: 36352355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
    Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC
    PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.